AU2001245988A1 - Microspheres for active embolization - Google Patents

Microspheres for active embolization

Info

Publication number
AU2001245988A1
AU2001245988A1 AU2001245988A AU4598801A AU2001245988A1 AU 2001245988 A1 AU2001245988 A1 AU 2001245988A1 AU 2001245988 A AU2001245988 A AU 2001245988A AU 4598801 A AU4598801 A AU 4598801A AU 2001245988 A1 AU2001245988 A1 AU 2001245988A1
Authority
AU
Australia
Prior art keywords
embolization
microspheres
angiogenic
present
injectable compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245988A
Inventor
Egisto Boschetti
Jean-Marie Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosphere Medical Inc
Original Assignee
Biosphere Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22707362&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001245988(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biosphere Medical Inc filed Critical Biosphere Medical Inc
Publication of AU2001245988A1 publication Critical patent/AU2001245988A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy. The present invention further relates to methods of embolization gene therapy, particularly for the treatment of angiogenic and non-angiogenic-dependent diseases, using the injectable compositions.
AU2001245988A 2000-03-24 2001-03-23 Microspheres for active embolization Abandoned AU2001245988A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19189900P 2000-03-24 2000-03-24
US60191899 2000-03-24
PCT/US2001/009619 WO2001072281A2 (en) 2000-03-24 2001-03-23 Microspheres for active embolization

Publications (1)

Publication Number Publication Date
AU2001245988A1 true AU2001245988A1 (en) 2001-10-08

Family

ID=22707362

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245988A Abandoned AU2001245988A1 (en) 2000-03-24 2001-03-23 Microspheres for active embolization

Country Status (10)

Country Link
US (4) US8697137B2 (en)
EP (3) EP1820495B1 (en)
JP (4) JP2003528130A (en)
KR (2) KR100872884B1 (en)
CN (2) CN1430505A (en)
AT (1) ATE374597T1 (en)
AU (1) AU2001245988A1 (en)
DE (2) DE60130743T2 (en)
ES (2) ES2551164T3 (en)
WO (1) WO2001072281A2 (en)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660301B1 (en) 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
FR2784580B1 (en) * 1998-10-16 2004-06-25 Biosepra Inc POLYVINYL-ALCOHOL MICROSPHERES AND METHODS OF MAKING THE SAME
AU2001245660B2 (en) 2000-03-13 2006-06-15 Biocompatibles Uk Limited Embolic compositions
ATE310752T1 (en) 2000-03-13 2005-12-15 Biocure Inc BIOMEDICAL ITEMS MADE OF HYDROGEL
AU2001249221A1 (en) 2000-03-20 2001-10-03 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
US6436424B1 (en) 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
US7338657B2 (en) * 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
DE60130743T2 (en) 2000-03-24 2008-07-17 Biosphere Medical, Inc., Rockland MICROBALLS FOR ACTIVE EMBOLIZATION
US20040266983A1 (en) * 2000-08-17 2004-12-30 Reeve Lorraine E Purified polyoxyalkylene block copolymers
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US20030236457A1 (en) * 2002-04-24 2003-12-25 Mericle Robert A. Method of endovascular brain mapping
US7332160B2 (en) 2002-07-12 2008-02-19 Boston Scientific Scimed, Inc. Medical device and method for tissue removal and repair
US7588825B2 (en) * 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
EP2724719A1 (en) * 2003-03-24 2014-04-30 Biosphere Medical, Inc. Temporary embolization using inverse thermosensitive polymers
CA2531894C (en) 2003-09-25 2014-02-11 Rutgers, The State University Inherently radiopaque polymeric products for embolotherapy
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
WO2005046438A2 (en) * 2003-11-06 2005-05-26 Pluromed, Inc. Internal clamp for surgical procedures
WO2005087193A2 (en) * 2004-03-11 2005-09-22 Biocompatibles Uk Limited Chemoembolisation involving an anthracycline compound
BRPI0510717B8 (en) * 2004-05-06 2021-05-25 Bioresponse Llc use of 3,3'-diindolylmethane (dim) or 2-(indol-3-ylmethyl)-3,3'-diindolylmethane (ltr)
US8821859B2 (en) * 2004-05-19 2014-09-02 Agency For Science, Technology And Research Methods and articles for the delivery of therapeutic agents
EP1600456A1 (en) * 2004-05-28 2005-11-30 Deutsches Krebsforschungszentrum Method for the purification of polymers carrying a lipophilic group
US20070258939A1 (en) * 2004-08-03 2007-11-08 Biocamparibles Uk Limited Drug Delivery from Embolic Agents
WO2006013376A2 (en) * 2004-08-04 2006-02-09 Biocompatibles Uk Limited Drug delivery of a cox inhibitor from embolic agents
ATE503465T1 (en) 2004-10-25 2011-04-15 Celonova Biosciences Germany Gmbh LOADABLE POLYPHOSPHAZENE-CONTAINING PARTICLES FOR THERAPEUTIC AND/OR DIAGNOSTIC APPLICATIONS AND PRODUCTION AND USE METHODS THEREOF
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US11426355B2 (en) 2004-10-25 2022-08-30 Varian Medical Systems, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
WO2006083458A2 (en) * 2004-12-30 2006-08-10 Bioresponse Llc Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associates conditions
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
ES2568782T3 (en) 2005-05-09 2016-05-04 Biosphere Medical, S.A. Compositions and methods of use of microspheres and non-ionic contrast agents
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
FR2892927B1 (en) * 2005-11-04 2008-01-11 Oreal USE OF A COSMETIC COMPOSITION COMPRISING FLEXIBLE SPHERICAL PARTICLES FOR SHAPING HAIR
JP5075130B2 (en) * 2006-01-24 2012-11-14 バイオコンパティブルズ ユーケー リミテッド Method of loading polymer particles with a drug
EP1986707A2 (en) * 2006-01-30 2008-11-05 Surgica Corporation Compressible intravascular embolization particles and related methods and delivery systems
EP2368581B1 (en) * 2006-01-30 2018-08-29 Biosphere Medical, Inc. Porous intravascular embolization particles and related methods
US7794755B2 (en) * 2006-04-11 2010-09-14 E.I. Du Pont De Nemours And Company Process for preparation of swellable and deformable microspheres
US8252339B2 (en) * 2006-04-11 2012-08-28 Massachusetts Institute Of Technology Medical treatment applications of swellable and deformable microspheres
US7838035B2 (en) 2006-04-11 2010-11-23 E. I. Du Pont De Nemours And Company Microsphere powder of high density, swellable, deformable, durable occlusion-forming microspheres
US8062673B2 (en) 2006-04-11 2011-11-22 E I Du Pont De Nemours And Company Process for embolization using swellable and deformable microspheres
CN100518719C (en) * 2006-07-05 2009-07-29 中国科学院大连化学物理研究所 Method for preparing composite substrate multifunctional arterial embolic agent
BRPI0717753B1 (en) * 2006-10-27 2022-04-12 Bioresponse, Llc Use of a composition comprising 50-250 mg of one or more dim-related indoles and one or more anti-protozoal agents, and, composition
CN105251035A (en) * 2006-12-11 2016-01-20 健赞公司 Perfusive organ hemostasis
AU2008218225B2 (en) * 2007-02-22 2014-05-15 Pluromed, Inc. Use of reverse thermosensitive polymers to control biological fluid flow following a medical procedure
US9987221B2 (en) * 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
WO2009073193A2 (en) * 2007-12-03 2009-06-11 The Johns Hopkins University Methods of synthesis and use of chemospheres
EP2123256A1 (en) 2008-05-19 2009-11-25 Ruhr-Universität Bochum Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
WO2010062678A2 (en) * 2008-10-30 2010-06-03 David Liu Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same
CA2754200A1 (en) * 2009-03-02 2010-09-10 Assistance Publique - Hopitaux De Paris Injectable biomaterial
WO2010143708A1 (en) * 2009-06-12 2010-12-16 富士フイルム株式会社 Targeting agent for neovascularization
WO2011044236A1 (en) 2009-10-06 2011-04-14 Regents Of The University Of Minnesota Bioresorbable embolization microspheres
EP2531220B1 (en) * 2009-12-18 2018-05-02 President and Fellows of Harvard College Active scaffolds for on-demand drug and cell delivery
EP2351779B1 (en) 2010-01-27 2019-04-24 Biosphere Medical, Inc. Microspheres and method of making the microspheres
KR101151688B1 (en) * 2010-05-18 2012-06-14 중앙대학교 산학협력단 Systems for preparing embolic microsphere
US9192746B2 (en) * 2010-06-07 2015-11-24 Cook Medical Technologies Llc Reperfusion catheter system
GB201101429D0 (en) * 2011-01-27 2011-03-16 Biocompatibles Uk Ltd Drug delivery system
BR112014000324A8 (en) * 2011-07-19 2019-01-29 Cellmosaic Inc cross-linking reagents, macromolecules, therapeutic conjugates and synthetic methods
WO2013177364A1 (en) 2012-05-24 2013-11-28 Biosphere Medical, Inc. Biomaterials suitable for use as drug eluting, magnetic resonance imaging detectable implants for vascular occlusion
CN103142491B (en) * 2013-02-06 2015-07-15 广东先强药业有限公司 Vidarabine monophosphate microsphere drug delivery system and preparation method thereof
CN103536974B (en) * 2013-07-05 2015-07-15 北京大学 Magnetic resonance imaging detectable in-situ liquid crystal precursor embolism composition, preparation and application thereof
CN103536972B (en) * 2013-07-05 2016-01-13 北京大学 The detectable liquid embolic compositions of nuclear magnetic resonance and Synthesis and applications thereof
US20150080940A1 (en) * 2013-09-13 2015-03-19 Cook Medical Technologies Llc Anti-tumor macrophage m1 morphology inducer
WO2015042170A1 (en) 2013-09-17 2015-03-26 Wayne State University Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds
BR112016005770B1 (en) 2013-09-19 2021-07-27 Terumo Corporation POLYMER PARTICLES
AU2014321278B2 (en) 2013-09-19 2016-11-10 Microvention, Inc. Polymer films
CN103550834B (en) * 2013-10-25 2015-07-15 北京大学 Embolism material composition as well as preparation method and use thereof
KR102287781B1 (en) 2013-11-08 2021-08-06 테루모 가부시키가이샤 Polymer particles
WO2016154592A1 (en) 2015-03-26 2016-09-29 Microvention, Inc. Embiolic particles
US10071181B1 (en) 2015-04-17 2018-09-11 Teleflex Innovations S.À.R.L. Resorbable embolization spheres
CN104865333B (en) * 2015-05-14 2016-08-24 武汉轻工大学 A kind of detection method of Arillus Longan proteoglycan
WO2017037523A1 (en) 2015-06-19 2017-03-09 Sillajen, Inc. Compositions and methods for viral embolization
GB201515602D0 (en) * 2015-09-03 2015-10-21 Biocompatibles Uk Ltd Polymers and microspheres
US10646524B2 (en) * 2015-09-08 2020-05-12 Sillajen, Inc. Modified oncolytic vaccinia viruses expressing a cytokine and a car-boxylesterase and methods of use thereof
US10053693B2 (en) 2016-01-19 2018-08-21 Mubin I. Syed Method for controlling obesity using minimally invasive means
US10182979B2 (en) 2016-03-22 2019-01-22 Regents Of The University Of Minnesota Biodegradable microspheres
TWI604819B (en) * 2016-04-13 2017-11-11 Bioabsorbable bone nail capable of developing under x-ray and its making method
JP6757464B2 (en) * 2016-07-21 2020-09-16 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． Composition for injection
US10328175B2 (en) 2016-09-28 2019-06-25 Terumo Corporation Polymer particles
WO2018070894A1 (en) * 2016-10-12 2018-04-19 Общество С Ограниченной Ответственностью "Технология Лекарств" Chemoembolization particles, method of producing same and use of same
CN110831526A (en) 2017-05-19 2020-02-21 波士顿科学国际有限公司 Systems and methods for submucosal tissue separation
WO2018218208A1 (en) 2017-05-26 2018-11-29 Bruin Biosciences, Inc. Chemoembolization agents
CN111278477A (en) * 2017-10-25 2020-06-12 精密医疗国际公司 Biodegradable and bio-metabolizable tumor sealant
EP3727342B1 (en) 2017-12-18 2022-02-09 C.R. Bard, Inc. Drug-loaded microbead compositions, embolization compositions and associated methods
US11590080B2 (en) 2017-12-18 2023-02-28 C.R. Bard, Inc. Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents
CN109010902A (en) * 2018-05-04 2018-12-18 南京大学 A kind of heparin spherex vascular occlusive agent and preparation method with antitumor action
WO2019227398A1 (en) * 2018-05-31 2019-12-05 Lin xi zhang Particle for occluding blood flow, preparation method therefor, and use thereof
CN108992431B (en) * 2018-09-30 2020-10-09 重庆医科大学附属永川医院 Doxorubicin embolism microsphere and preparation method thereof
CN112646082B (en) * 2019-10-10 2023-06-23 陈忠 Acrylate polymer microsphere aggregate and preparation method thereof
CN112791228A (en) * 2019-11-13 2021-05-14 太阳雨林（厦门）生物医药有限公司 Slow-release embolism microsphere for pulmonary tuberculosis hemoptysis
CN112972753A (en) * 2019-12-02 2021-06-18 太阳雨林（厦门）生物医药有限公司 Sustained-release embolism microsphere for treating bronchiectasis hemoptysis caused by chronic inflammation
EP4213903A1 (en) * 2020-09-16 2023-07-26 Said Farha System and method for integrated blood vessel embolization and localized drug delivery
CN112305123B (en) * 2020-10-30 2021-12-28 河北医科大学第二医院 Application of small molecular substance in atherosclerotic cerebral infarction
CN113975453B (en) * 2021-09-10 2023-03-07 苏州浩微生物医疗科技有限公司 Hydrogel embolism microsphere and preparation method thereof
CN113694248B (en) * 2021-09-13 2023-03-17 中山大学 Embolism microsphere based on soluble starch and preparation and application thereof
WO2023200921A1 (en) * 2022-04-13 2023-10-19 Ned Medical, Inc. Radioembolic beads and methods for treatment of tumor cells

Family Cites Families (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3673125A (en) 1969-05-10 1972-06-27 Kanegafuchi Spinning Co Ltd Method of producing polyvinyl acetal porous articles
US3919411A (en) 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
JPS49108168A (en) 1973-02-16 1974-10-15
US4197846A (en) 1974-10-09 1980-04-15 Louis Bucalo Method for structure for situating in a living body agents for treating the body
JPS5350290A (en) 1976-10-18 1978-05-08 Sumitomo Chem Co Ltd Preparation f hydrogel
FR2378808A1 (en) 1977-01-28 1978-08-25 Mar Pha Etu Expl Marques NEW HYDROPHILIC COPOLYMERS BASED ON N- (TRIS (HYDROXY-METHYL) METHYL) ACRYLAMIDE OR N- (TRIS (HYDROXYMETHYL) METHYL) METHACRYLAMIDE, THEIR PREPARATION AND THEIR USE IN SEPARATION TECHNIQUES
CS204190B1 (en) 1978-02-22 1981-03-31 Jaroslav Drobnik Activation method for hydrxyl groups containing insoluble carriers
DE2935712A1 (en) 1978-09-07 1980-03-20 Sumitomo Chemical Co METHOD FOR PRODUCING STRONG ABSORBENT POLYMERISATES
US4314032A (en) 1978-10-26 1982-02-02 Kureha Kagaku Kogyo Kabushiki Kaisha Crosslinked polyvinyl alcohol gel
US4268495A (en) 1979-01-08 1981-05-19 Ethicon, Inc. Injectable embolization and occlusion solution
US4306031A (en) 1979-08-14 1981-12-15 Mitsubishi Chemical Industries Limited Weakly acidic cation exchange resin and process for producing same
FR2482112B1 (en) 1980-05-09 1985-06-07 Pharmindustrie NOVEL HYDROPHILIC COPOLYMERS BASED ON N- (TRIS (HYDROXYMETHYL) METHYL) ACRYLAMIDE, PROCESSES FOR THEIR PREPARATION, AQUEOUS GELS OF SAID COPOLYMERS AND THEIR USE AS ION EXCHANGERS
GB2088392B (en) 1980-12-03 1984-05-02 Sumitomo Chemical Co Production of hydrogels
JPS57128709A (en) 1981-02-03 1982-08-10 Sumitomo Chem Co Ltd Preparation of hydrogel
US4413070A (en) 1981-03-30 1983-11-01 California Institute Of Technology Polyacrolein microspheres
US4622362A (en) 1981-03-30 1986-11-11 California Institute Of Technology Polyacrolein microspheres
JPS5988418A (en) * 1982-11-08 1984-05-22 Unitika Ltd Prolonged releasing embolic agent for antiulcer substance
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4500658A (en) 1983-06-06 1985-02-19 Austenal International, Inc. Radiopaque acrylic resin
CA1225585A (en) 1983-06-30 1987-08-18 Maria T. Litvinova Composition for embolization of blood vessels
GB8418772D0 (en) 1984-07-24 1984-08-30 Geistlich Soehne Ag Chemical substances
FR2573436B1 (en) 1984-11-20 1989-02-17 Pasteur Institut RECOMBINANT DNA COMPRISING A NUCLEOTIDE SEQUENCE ENCODING A DETERMINED POLYPEPTIDE UNDER THE CONTROL OF AN ADENOVIRUS PROMOTER, VECTORS CONTAINING THIS RECOMBINANT DNA, EUKARYOT CELLS TRANSFORMED BY THIS RECOMBINANT DNA, THE CONSTITUTION OF VACCINES
US4680171A (en) 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
US5186922A (en) 1985-03-15 1993-02-16 See/Shell Biotechnology, Inc. Use of biodegradable microspheres labeled with imaging energy constrast materials
DE122007000007I1 (en) 1986-04-09 2007-05-16 Genzyme Corp Genetically transformed animals secreting a desired protein in milk
US4803075A (en) 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
JPS6317904A (en) 1986-07-09 1988-01-25 Mitsubishi Chem Ind Ltd Production of crosslinked porous polyvinyl alcohol particle
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4803072A (en) * 1986-09-10 1989-02-07 Smithkline Beckman Corporation Immunomodulation
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US4795741A (en) 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
CA1329800C (en) 1987-12-29 1994-05-24 Hiroaki Takayanagi Composite separating agent
AU3049489A (en) 1988-02-12 1989-09-06 Brigitte De Zaepffel Crosslinked hydrophilic copolymer for medical and paramedical use
JPH064713B2 (en) 1988-07-22 1994-01-19 テルモ株式会社 Biocompatible material
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
JPH0286838A (en) 1988-09-22 1990-03-27 Terumo Corp Water insoluble hydrogel and production thereof
US5550187A (en) 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
DE3841401A1 (en) 1988-12-08 1990-06-13 Martin Lemperle ALLOPLASTIC IMPLANT
US5258028A (en) 1988-12-12 1993-11-02 Ersek Robert A Textured micro implants
US5092883A (en) 1988-12-28 1992-03-03 Eppley Barry L Method for promoting soft connective tissue growth and repair in mammals
WO1990008756A1 (en) 1989-01-27 1990-08-09 MERCK Patent Gesellschaft mit beschränkter Haftung Diphenylethanes
FR2645866B1 (en) 1989-04-17 1991-07-05 Centre Nat Rech Scient NEW LIPOPOLYAMINES, THEIR PREPARATION AND THEIR USE
CA2017570C (en) 1989-05-31 2000-12-19 James R. Gross Porous structure of an absorbent polymer
US5007940A (en) 1989-06-09 1991-04-16 American Medical Systems, Inc. Injectable polymeric bodies
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5147937A (en) 1990-03-22 1992-09-15 Rohm And Haas Company Process for making controlled, uniform-sized particles in the 1 to 50 micrometer range
US5202352A (en) * 1990-08-08 1993-04-13 Takeda Chemical Industries, Ltd. Intravascular embolizing agent containing angiogenesis-inhibiting substance
JP3120187B2 (en) * 1990-08-08 2000-12-25 武田薬品工業株式会社 Endovascular embolic agent containing angiogenesis inhibitor
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5117577A (en) 1990-11-05 1992-06-02 Gary Burghoff Fish attractor device
JPH06507904A (en) 1991-05-23 1994-09-08 イマアーレクス・フアーマシユーチカル・コーポレーシヨン Oil-soluble compounds for magnetic resonance imaging
FR2676927B1 (en) 1991-05-29 1995-06-23 Ibf MICROSPHERES FOR USE IN THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THEM.
US5554658A (en) 1991-08-06 1996-09-10 Rosenblatt; Solomon Injection molded PVA Sponge
EP0529910B1 (en) 1991-08-23 1996-03-13 Nippon Shokubai Co., Ltd. Biodegradable hydrophilic crosslinked polymer, process for producing it, and uses thereof
JPH082985B2 (en) 1991-08-26 1996-01-17 東京シート株式会社 Method for manufacturing urethane foam molded product with high-density surface layer
JP3356447B2 (en) 1991-10-16 2002-12-16 テルモ株式会社 Vascular lesion embolic material composed of dried polymer gel
BR9306038A (en) 1992-02-28 1998-01-13 Univ Texas Light-curing biodegradable hydrogels as contact materials for controlled release fabrics and conductors
JPH05294839A (en) * 1992-04-20 1993-11-09 Biomaterial Universe Kk Microscopic sphere of polymer containing cisplatin and decomposable and absorbable in vivo and its production
JPH0656676A (en) * 1992-08-05 1994-03-01 Hori Shinichi Suspension for blood vessel embolization
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US5654006A (en) * 1993-02-12 1997-08-05 Mayo Foundation For Medical Education And Research Condensed-phase microparticle composition and method
US5629327A (en) 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
DK0809110T3 (en) 1993-03-09 2004-05-24 Baxter Int Macromolecular microparticles and methods of preparation
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
JP2995090B2 (en) 1993-03-19 1999-12-27 キユー・メド・アクチエボラーグ Compositions and methods for tissue augmentation
FR2705361B1 (en) 1993-05-18 1995-08-04 Centre Nat Rech Scient Viral vectors and use in gene therapy.
FR2707664B1 (en) 1993-07-13 1995-09-29 Centre Nat Rech Scient Viral vectors and use in gene therapy.
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
ATE502664T1 (en) * 1993-07-19 2011-04-15 Angiotech Pharm Inc METHOD OF PRODUCTION OF A STENT WITH ANTI-ANGIOGENIC COMPOSITION
US20030203976A1 (en) * 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
US5639872A (en) * 1993-07-27 1997-06-17 Hybridon, Inc. Human VEGF-specific oligonucleotides
GB2281861B (en) 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
ATE243501T1 (en) 1993-11-18 2003-07-15 Sirtex Medical Ltd CONTROLLED RELEASE PREPARATION
US5698443A (en) 1995-06-27 1997-12-16 Calydon, Inc. Tissue specific viral vectors
US5830686A (en) 1994-01-13 1998-11-03 Calydon Tissue-specific enhancer active in prostate
US5583162A (en) 1994-06-06 1996-12-10 Biopore Corporation Polymeric microbeads and method of preparation
US5451406A (en) 1994-07-14 1995-09-19 Advanced Uroscience, Inc. Tissue injectable composition and method of use
UA10911C2 (en) 1994-08-10 1996-12-25 Мале Впроваджувальне Підприємство "Іhтерфалл" Biocompatible hydrogel
EP0785774B1 (en) 1994-10-12 2001-01-31 Focal, Inc. Targeted delivery via biodegradable polymers
US6099864A (en) * 1994-12-02 2000-08-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration In situ activation of microcapsules
US5716404A (en) 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US5955108A (en) 1994-12-16 1999-09-21 Quadrant Healthcare (Uk) Limited Cross-linked microparticles and their use as therapeutic vehicles
JP3625837B2 (en) 1995-01-27 2005-03-02 シメッド ライフ システムズ，インコーポレイテッド Embolic device
US5855610A (en) 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US5888546A (en) 1995-08-28 1999-03-30 The Regents Of The University Of California Embolic material for endovascular occlusion of abnormal vasculature and method for using the same
US5985177A (en) 1995-12-14 1999-11-16 Shiseido Co., Ltd. O/W/O type multiple emulsion and method of preparing the same
US5752974A (en) 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
DE19601699A1 (en) 1996-01-18 1997-07-24 Wacker Chemie Gmbh Redispersible polymer powders and aqueous polymer dispersions obtainable therefrom
US5785977A (en) 1996-02-07 1998-07-28 Breithbarth; Richard Non-metallic microparticle carrier materials
US5611344A (en) 1996-03-05 1997-03-18 Acusphere, Inc. Microencapsulated fluorinated gases for use as imaging agents
US6060530A (en) 1996-04-04 2000-05-09 Novartis Ag Process for manufacture of a porous polymer by use of a porogen
US5823198A (en) 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US6083484A (en) * 1996-10-17 2000-07-04 Molecular Biosystems, Inc. Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents
US5925683A (en) 1996-10-17 1999-07-20 Target Therapeutics, Inc. Liquid embolic agents
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
JP2001524096A (en) 1997-04-24 2001-11-27 ニコムド イメージング エイエス Embolic treatment using insoluble microparticles or vesicles containing contrast agents
US5861149A (en) 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
US6048908A (en) 1997-06-27 2000-04-11 Biopore Corporation Hydrophilic polymeric material
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
AU8877098A (en) * 1997-09-05 1999-03-29 Nycomed Imaging As Polymer particles made of polyvinyl alcohol and comprising contrast agent for chemoembolization
US6548047B1 (en) * 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6015541A (en) 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
GB9727518D0 (en) * 1997-12-31 1998-02-25 Nycomed Imaging As Use
AU742786B2 (en) 1998-03-06 2002-01-10 Biosphere Medical, Inc. Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
US5891470A (en) 1998-04-17 1999-04-06 Advanced Polymer Systems, Inc. Softgel formulation containing retinol
US6224794B1 (en) * 1998-05-06 2001-05-01 Angiotech Pharmaceuticals, Inc. Methods for microsphere production
US6165193A (en) 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
US6316011B1 (en) 1998-08-04 2001-11-13 Madash, Llc End modified thermal responsive hydrogels
US6315709B1 (en) 1998-08-07 2001-11-13 Stereotaxis, Inc. Magnetic vascular defect treatment system
CA2248592A1 (en) * 1998-08-31 2000-02-29 Christopher D. Batich Microspheres for use in the treatment of cancer
FR2784580B1 (en) 1998-10-16 2004-06-25 Biosepra Inc POLYVINYL-ALCOHOL MICROSPHERES AND METHODS OF MAKING THE SAME
US20040047804A1 (en) 1998-10-29 2004-03-11 The General Hospital Corporation, A Massachusetts Corporation Enhanced radiation therapy
US6955661B1 (en) * 1999-01-25 2005-10-18 Atrium Medical Corporation Expandable fluoropolymer device for delivery of therapeutic agents and method of making
US6296604B1 (en) * 1999-03-17 2001-10-02 Stereotaxis, Inc. Methods of and compositions for treating vascular defects
US6710126B1 (en) * 1999-11-15 2004-03-23 Bio Cure, Inc. Degradable poly(vinyl alcohol) hydrogels
KR100335866B1 (en) 2000-01-06 2002-05-10 박호군 Microspheric Embolic Materials Having Duel Structure of Poly(Vinyl Acetate) Core/Poly(Vinyl Alcohol) Shell, and Method for Preparing The Same
US6652883B2 (en) 2000-03-13 2003-11-25 Biocure, Inc. Tissue bulking and coating compositions
AU2001245660B2 (en) * 2000-03-13 2006-06-15 Biocompatibles Uk Limited Embolic compositions
US7338657B2 (en) 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
AU2001249221A1 (en) 2000-03-20 2001-10-03 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
US6436424B1 (en) 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
DE60130743T2 (en) * 2000-03-24 2008-07-17 Biosphere Medical, Inc., Rockland MICROBALLS FOR ACTIVE EMBOLIZATION
US20030212022A1 (en) 2001-03-23 2003-11-13 Jean-Marie Vogel Compositions and methods for gene therapy
FR2808026B1 (en) 2000-04-25 2002-06-14 Alexandre Laurent BIOMATERIAL BASED ON HYDROPHILIC POLYMER HAVING A SPECIFIC SIGNAL IN MAGNETIC RESONANCE IMAGING AND METHOD FOR PREPARING SUCH A BIOMATERIAL
US6537569B2 (en) 2001-02-14 2003-03-25 Microvention, Inc. Radiation cross-linked hydrogels
JP4094823B2 (en) 2001-04-03 2008-06-04 日本碍子株式会社 Honeycomb structure and assembly thereof
WO2002100444A1 (en) 2001-06-08 2002-12-19 Biosphere Medical Inc. Colloidal metal labelled microparticles, their production and use
US6488952B1 (en) 2001-08-28 2002-12-03 John P. Kennedy Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
US6911219B2 (en) 2001-09-27 2005-06-28 Surgica Corporation Partially acetalized polyvinyl alcohol embolization particles, compositions containing those particles and methods of making and using them
US7131997B2 (en) 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
EP1490120B1 (en) 2002-03-29 2009-11-11 Boston Scientific Limited Embolization
US7053134B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
US7034004B2 (en) 2002-05-07 2006-04-25 University Of Florida Peptides and methods for the control of obesity
US7838699B2 (en) 2002-05-08 2010-11-23 Biosphere Medical Embolization using degradable crosslinked hydrogels
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US20040197302A1 (en) 2002-10-15 2004-10-07 Porter Christopher H. Prepolymeric materials for site specific delivery to the body
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7588825B2 (en) 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US20040091553A1 (en) 2002-11-12 2004-05-13 West Agro, Inc Composition and method for mammary disinfection during winter conditions
ES2308149T3 (en) 2003-02-12 2008-12-01 Biocompatibles Uk Limited COMPOSITION FOR THE CHEMIOEMBOLOTHERAPY OF SOLID TUMORS.
US20040161466A1 (en) 2003-02-14 2004-08-19 Biocompatibles Uk Limited Chemoembolisation
US20060057198A1 (en) 2003-02-21 2006-03-16 Biocompatibles Uk Limited Drug delivery from embolic agents
EP2724719A1 (en) 2003-03-24 2014-04-30 Biosphere Medical, Inc. Temporary embolization using inverse thermosensitive polymers
WO2005044224A2 (en) 2003-05-02 2005-05-19 Case Western Reserve University Drug delivery system based on polymer nanoshells
JP4342219B2 (en) 2003-06-13 2009-10-14 株式会社ブリヂストン INORGANIC MOLD COMPOSITION COMPOSITION AND METHOD FOR PRODUCING TIRE MOLD USING THE SAME
CA2555866A1 (en) * 2004-02-16 2005-08-25 Proteosys Ag Diagnostic markers for cancer
WO2005087193A2 (en) 2004-03-11 2005-09-22 Biocompatibles Uk Limited Chemoembolisation involving an anthracycline compound
JP2005315107A (en) * 2004-04-27 2005-11-10 Toyota Motor Corp Eight-cylinder engine
WO2006013376A2 (en) 2004-08-04 2006-02-09 Biocompatibles Uk Limited Drug delivery of a cox inhibitor from embolic agents
WO2006027567A2 (en) 2004-09-07 2006-03-16 Biocompatibles Uk Limited Drug delivery from embolic agents
ATE503465T1 (en) 2004-10-25 2011-04-15 Celonova Biosciences Germany Gmbh LOADABLE POLYPHOSPHAZENE-CONTAINING PARTICLES FOR THERAPEUTIC AND/OR DIAGNOSTIC APPLICATIONS AND PRODUCTION AND USE METHODS THEREOF
ES2568782T3 (en) 2005-05-09 2016-05-04 Biosphere Medical, S.A. Compositions and methods of use of microspheres and non-ionic contrast agents
JP4180582B2 (en) 2005-05-16 2008-11-12 富士通株式会社 Storage device
US7210338B2 (en) 2005-07-29 2007-05-01 Honda Motor Co., Ltd. Valve testing device having integrated purge circuit and method of valve testing
DE602006014417D1 (en) 2005-08-10 2010-07-01 Nxp Bv INSPECT AN INTEGRATED CIRCUIT CONTAINING SECRET INFORMATION
WO2007032561A1 (en) 2005-09-16 2007-03-22 Shiseido Company, Ltd. Novel inhibitor of vascular endothelial growth factor expression
US7626626B2 (en) 2006-01-13 2009-12-01 Micron Technology, Inc. Method and apparatus providing pixel storage gate charge sensing for electronic stabilization in imagers
JP5075130B2 (en) 2006-01-24 2012-11-14 バイオコンパティブルズ ユーケー リミテッド Method of loading polymer particles with a drug
EP2368581B1 (en) 2006-01-30 2018-08-29 Biosphere Medical, Inc. Porous intravascular embolization particles and related methods
EP1986707A2 (en) 2006-01-30 2008-11-05 Surgica Corporation Compressible intravascular embolization particles and related methods and delivery systems
GB0619869D0 (en) 2006-10-07 2006-11-15 Regentec Ltd Porous particles
JP5000969B2 (en) 2006-10-13 2012-08-15 株式会社リコー Color image forming apparatus and color misregistration correction method
WO2010062678A2 (en) 2008-10-30 2010-06-03 David Liu Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same
EP2351779B1 (en) 2010-01-27 2019-04-24 Biosphere Medical, Inc. Microspheres and method of making the microspheres
US9872655B2 (en) * 2012-03-30 2018-01-23 Siemens Aktiengesellschaft PAE treatment for BPH
JP6056676B2 (en) * 2013-06-21 2017-01-11 富士通株式会社 Electronic device and manufacturing method thereof

Also Published As

Publication number Publication date
EP2286799A3 (en) 2012-03-07
DE01918975T1 (en) 2006-04-13
US9308169B2 (en) 2016-04-12
EP1267839B1 (en) 2007-10-03
CN1430505A (en) 2003-07-16
EP1820495B1 (en) 2017-03-01
ES2551164T3 (en) 2015-11-16
DE60130743T2 (en) 2008-07-17
US20120213831A1 (en) 2012-08-23
CN101708165A (en) 2010-05-19
ATE374597T1 (en) 2007-10-15
KR100872884B1 (en) 2008-12-10
US20030211165A1 (en) 2003-11-13
ES2254042T1 (en) 2006-06-16
US8697137B2 (en) 2014-04-15
KR20080046750A (en) 2008-05-27
US20120141379A1 (en) 2012-06-07
DE60130743D1 (en) 2007-11-15
JP2003528130A (en) 2003-09-24
WO2001072281A3 (en) 2002-02-28
ES2254042T3 (en) 2008-03-16
EP1267839A2 (en) 2003-01-02
JP2016147885A (en) 2016-08-18
EP1820495A2 (en) 2007-08-22
US10265271B2 (en) 2019-04-23
EP2286799B1 (en) 2015-07-29
KR20030011803A (en) 2003-02-11
WO2001072281A2 (en) 2001-10-04
JP2013082743A (en) 2013-05-09
US8741351B2 (en) 2014-06-03
US20080220077A1 (en) 2008-09-11
EP2286799A2 (en) 2011-02-23
JP2008214355A (en) 2008-09-18
EP1820495A3 (en) 2008-04-02

Similar Documents

Publication Publication Date Title
AU2001245988A1 (en) Microspheres for active embolization
WO2001072280A3 (en) Microspheres for gene therapy
WO2003082188A3 (en) Methods and drug delivery systems for the treatment of orofacial diseases
NO20005190D0 (en) Therapeutic angiogenic factors and methods for their use
MXPA03004546A (en) Treatment of mucositis.
AU5056196A (en) Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof
WO2006002366A3 (en) Biodegradable ocular devices, methods and systems
HK1056311A1 (en) Topical pharmaceutical formulations and methods of treatment
WO2003044076A8 (en) Bioerodible poly(ortho esters) containing amine groups, and block copolymers containing them
CA2235919A1 (en) Non-polymeric sustained release delivery system
WO2003061578A3 (en) Compositions for treatment or prevention of bioterrorism
WO2005110436A3 (en) Macromolecule-containing sustained release intraocular implants and related methods
MXPA05007146A (en) Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles.
EP2407203A3 (en) Solid therapeutic agent for use in an implantable drug delivery device
EP3056229A3 (en) The local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque
MXPA03010085A (en) Composition and methods for treatment of hyperplasia.
ATE198979T1 (en) TARGETED DISHES ADMINISTERED USING BIODEGRADABLE POLYMERS
WO1998029105A3 (en) Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
ES2287660T3 (en) PHARMACEUTICAL COMPOSITION OF PEPTIDIC DERIVATIVES OF TROMBINA.
EP1982695A3 (en) Manufacture of long term drug delivery devices with polyurethane
WO2004034975A3 (en) Sustained release profile modification
WO2004087065A8 (en) Compositions for induction of a therapeutic response
EP1569664A4 (en) Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
WO2004012676A3 (en) Drug-loaded biological material chemically treated with genipin
WO2007042040A3 (en) TREATMENT OF RETINOPATHIES USING GFRα3 AGONISTS